WO1992013951A1 - Production de serumalbumine humaine dans des cellules de levure methylotrophique - Google Patents
Production de serumalbumine humaine dans des cellules de levure methylotrophique Download PDFInfo
- Publication number
- WO1992013951A1 WO1992013951A1 PCT/US1992/001015 US9201015W WO9213951A1 WO 1992013951 A1 WO1992013951 A1 WO 1992013951A1 US 9201015 W US9201015 W US 9201015W WO 9213951 A1 WO9213951 A1 WO 9213951A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hsa
- dna fragment
- dna
- pastoris
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Definitions
- HSA peptides can very efficiently be produced in, and secreted from, methylotrophic yeast such as P. pastoris, by transforming a methylotrophic yeast with, and preferably integrating into the yeast genome, at least one copy of a first DNA sequence operably encoding an HSA peptide, wherein said first DNA sequence is operably associated with a second DNA sequence encoding a secretion signal sequence selected from the S.
- methylotrophic yeast such as P. pastoris
- S. cerevisiae AMF pre-pro sequence including the proteolytic processing site: lys-arg, or
- HSA peptides are produced by methylotrophic yeast cells containing in their genome at least one copy of a DNA sequence operably encoding HSA peptides operably associated with DNA encoding a secretion signal sequence selected from (1) the S. cerevisiae AMF pre-pro sequence (including the proteolytic processing site: lys-arg), or (2) the native HSA secretion signal sequence, both under the regulation of a promoter region of a methanol responsive gene of a methylotrophic yeast.
- a DNA sequence operably encoding HSA peptides includes DNA sequences encoding the 585 amino acid form of HSA or any other "HSA peptide" as defined hereinabove.
- the expression cassette is integrated into the host genome by any of the gene addition or replacement techniques known in the art. such as by one-step gene replacement [see e.g., Rothstein, Methods Enzvmol. 101- 202 (1983); Cregg et al., Bio/Technology 5 , 479 (1987)] or by two-step gene replacement methods [see e.g., Scherer and Davis, Proc. Natl. Acad. Sci. USA. 76, 4951 (1979)].
- Single-stranded vector was prepared from positive plaques and used to transform JM103 cells. The resultant plaques were screened again and single positives were sequenced. One mutagenized clone, pHSA102, was selected and sequenced to verify the addition of EcoRI and BamHI restriction sites.
- the mutagenized clone, pHSA105 was sequenced to verify the addition of the signal sequence and t._.a
- Plasmid pBR322 ⁇ RIBGL was digested with a Sail and Bglll and the large fragment (approximately 2.97 kbp) was isolated.
- Plasmid pBSAGISI which is described in European Patent Application Publication No. 0 226 752, was" digested completely with Bglll and Xho and an approximately 850 bp fragment from a region of the P. pastoris AOXl locus downstream from the AOXl gene transcription terminator (relative to the direction of transcription from the AOXl promoter) was isolated.
- Plasmid pA0 ⁇ 04 has one Sall-Clal fragment of about 1.5 kbp and another of abut 5.0 kbp and a Clal-Clal fragment of 1.3 kbp; this indicates that the direction of transcription of the HIS4 gene in the plasmid is the same as the direction of transcription of the ampicillin resistance gene and opposite the direction of transcription from the AOXl promoter.
- the orientation of the HIS4 gene in pA0804 is not critical to the function of the plasmid or of its derivatives with cDNA coding segments inserted at the EcoRI site between the AOXl promoter and terminator segments. Thus, a plasmid with the HIS4 gene in the orientation opposite that of the HIS4 gene in pA0804 would also be effective for use in accordance with the present invention. h. Construction of plasmid pA0815
- Goat anti-HSA antibody was obtained from Atlantic Antibodies (Scarborough, ME) .
- the horseradish peroxidase substrate, o-phenylenediamine (OPD) was purchased from Sigma Chemicals (St. Louis, MO) . All other chemicals were reagent grade and obtained from general suppliers. b. Method
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
Abstract
On prépare de la sérumalbumine humaine, polypeptide naturelle à chaîne unique, en cultivant des transformants de levure méthylotrophique dont le génome renferme au moins une copie d'une séquence d'ADN qui code, de manière efficace, pour la sérumalbumine humaine (HSA) en association fonctionnelle avec une séquence d'ADN qui code pour une séquence de signaux de sécrétion choisie entre: (1) la séquence pré-pro du facteur de croisement alpha de S. cerevisiae (y compris le site de traitement protéolytique: lys-arg), ou (2) la séquence de signaux de sécrétion de la sérumalbumine humaine native, dans laquelle le fragment qui code pour celle-ci et la séquence de signaux de sécrétion sont régulés par une région de promotion d'un gène d'une levure méthylotrophique dans des conditions permettant l'expression desdites séquences d'ADN, ainsi que la sécrétion de l'HSA dans le milieu de culture. On décrit également de nouveaux fragments d'ADN et de nouvelles souches recombinantes de levure utiles à la mise en ÷uvre de cette invention.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65004091A | 1991-02-04 | 1991-02-04 | |
US650,040 | 1991-02-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992013951A1 true WO1992013951A1 (fr) | 1992-08-20 |
Family
ID=24607217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/001015 WO1992013951A1 (fr) | 1991-02-04 | 1992-02-04 | Production de serumalbumine humaine dans des cellules de levure methylotrophique |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1992013951A1 (fr) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995007356A1 (fr) * | 1993-09-04 | 1995-03-16 | Basf Aktiengesellschaft | Procede de preparation de proteines par recombinaison dans la levure d'hansenula |
WO1995035384A1 (fr) * | 1994-06-17 | 1995-12-28 | Novo Nordisk A/S | Proteines comportant une extension a l'extremite n-terminale, exprimees par une levure |
US5541112A (en) * | 1991-04-01 | 1996-07-30 | Salk Institute Biotechnology/Industrial Associates | Genes which influence pichia proteolytic activity, and uses therefor |
EP0736605A1 (fr) * | 1994-10-25 | 1996-10-09 | The Green Cross Corporation | Procede de production de proteines |
US5612198A (en) * | 1990-09-04 | 1997-03-18 | The Salk Institute | Production of insulin-like growth factor-1 in methylotrophic yeast cells |
EP0794256A2 (fr) * | 1996-03-04 | 1997-09-10 | Suntory Limited | Procédé de culture de micro-organismes capable de métaboliser le méthanol |
WO1999000518A1 (fr) * | 1997-06-26 | 1999-01-07 | Abbott Laboratories | Membre de la famille du facteur de necrose tumorale (tnf) utile pour le traitement et le diagnostic de maladies |
EP0947581A1 (fr) * | 1996-08-08 | 1999-10-06 | Yoshitomi Pharmaceutical Industries, Ltd. | Milieu de culture et ses applications |
EP1008651A2 (fr) * | 1998-12-09 | 2000-06-14 | Bioteknologisk Institut | Séquences d'ADN modifiées, codantes pour l'hexose oxidase, et leur usage |
US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
US6867037B1 (en) * | 1998-08-10 | 2005-03-15 | Meiji Dairies Corp. | High level secretory expression system of intact MK family protein |
WO2015041718A1 (fr) * | 2013-09-20 | 2015-03-26 | The General Hospital Corporation | Utilisations de protéines de type hormone anti-müllérienne (ham) modifiée pour le traitement de maladies neurodégénératives |
US11084860B2 (en) | 2013-03-12 | 2021-08-10 | The General Hospital Corporation | Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases |
US11130979B2 (en) | 2017-06-20 | 2021-09-28 | Albumedix Ltd | Protein expression strains |
US11135269B2 (en) | 2013-12-11 | 2021-10-05 | The General Hospital Corporation | Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation |
US11518793B2 (en) | 2016-12-14 | 2022-12-06 | The General Hospital Corporation | Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation |
EP4202035A1 (fr) | 2021-12-22 | 2023-06-28 | Gelita AG | Expression améliorée de peptides |
Citations (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0263311A2 (fr) * | 1986-09-22 | 1988-04-13 | Phillips Petroleum Company | Production du facteur de nécrose de tumeurs par des levures |
AU1469988A (en) * | 1985-10-25 | 1988-07-21 | Research Corporation Technologies, Inc. | Dna fragment |
US4808537A (en) * | 1984-10-30 | 1989-02-28 | Phillips Petroleum Company | Methanol inducible genes obtained from pichia and methods of use |
US4812405A (en) * | 1986-02-18 | 1989-03-14 | Phillips Petroleum Company | Double auxotrophic mutants of Pichia pastoris and methods for preparation |
US4816564A (en) * | 1986-01-31 | 1989-03-28 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
US4818700A (en) * | 1985-10-25 | 1989-04-04 | Phillips Petroleum Company | Pichia pastoris argininosuccinate lyase gene and uses thereof |
US4837148A (en) * | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
US4855231A (en) * | 1984-10-30 | 1989-08-08 | Phillips Petroleum Company | Regulatory region for heterologous gene expression in yeast |
US4857467A (en) * | 1986-07-23 | 1989-08-15 | Phillips Petroleum Company | Carbon and energy source markers for transformation of strains of the genes Pichia |
EP0337492A1 (fr) * | 1988-04-15 | 1989-10-18 | Research Corporation Technologies, Inc. | Purification de protéines de l'hépatite |
GB2217332A (en) * | 1988-04-11 | 1989-10-25 | Phillips Petroleum Co | Expression of salmon growth hormone in methylotrophic yeast of genus pichia |
EP0339567A1 (fr) * | 1988-04-25 | 1989-11-02 | Phillips Petroleum Company | Expression de protéine de PreS 2 de l'hépatite B en levures méthylotrophiques |
US4879231A (en) * | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
US4885242A (en) * | 1984-10-30 | 1989-12-05 | Phillips Petroleum Company | Genes from pichia histidine pathway and uses thereof |
EP0344459A2 (fr) * | 1988-04-25 | 1989-12-06 | Research Corporation Technologies, Inc. | Expression de l'albumine du sérum humain dans des levures méthylotrophigues |
US4895800A (en) * | 1985-11-26 | 1990-01-23 | Phillips Petroleum Company | Yeast production of hepatitis B surface antigen |
WO1990002810A1 (fr) * | 1988-09-09 | 1990-03-22 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production de polypeptides d'interleukine-2 dans des cellules de levure de pichia pastoris |
WO1990003431A1 (fr) * | 1988-09-26 | 1990-04-05 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Fermentation de levure de recombinaison a alimentation melangee |
US4929555A (en) * | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
WO1990009434A1 (fr) * | 1989-02-13 | 1990-08-23 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production de peroxyde dismutase dans des cellules de levure de pichia pastoris |
WO1990010697A1 (fr) * | 1989-03-15 | 1990-09-20 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production du facteur de croissance epidermique dans des cellules methylotrophiques de levure |
US4963483A (en) * | 1987-10-13 | 1990-10-16 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
US5011915A (en) * | 1987-10-26 | 1991-04-30 | Merck & Co., Inc. | Process for purifying recombinant hepatitis antigens |
US5026828A (en) * | 1987-02-27 | 1991-06-25 | Merck & Co., Inc. | Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast |
US5032516A (en) * | 1985-10-25 | 1991-07-16 | Phillips Petroleum Company | Pichia pastoris alcohol oxidase II regulatory region |
US5041236A (en) * | 1989-10-27 | 1991-08-20 | The Procter & Gamble Company | Antimicrobial methods and compositions employing certain lysozymes and endoglycosidases |
US5082778A (en) * | 1986-06-03 | 1992-01-21 | Unilever Patent Holdings B.V. | Production of guar alpha-galactosidase by hosts transformed with recombinant dna. methods |
US5102989A (en) * | 1991-03-15 | 1992-04-07 | Merck & Co., Inc. | Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells |
-
1992
- 1992-02-04 WO PCT/US1992/001015 patent/WO1992013951A1/fr unknown
Patent Citations (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4837148A (en) * | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
US4879231A (en) * | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
US4808537A (en) * | 1984-10-30 | 1989-02-28 | Phillips Petroleum Company | Methanol inducible genes obtained from pichia and methods of use |
US4885242A (en) * | 1984-10-30 | 1989-12-05 | Phillips Petroleum Company | Genes from pichia histidine pathway and uses thereof |
US4855231A (en) * | 1984-10-30 | 1989-08-08 | Phillips Petroleum Company | Regulatory region for heterologous gene expression in yeast |
US5032516A (en) * | 1985-10-25 | 1991-07-16 | Phillips Petroleum Company | Pichia pastoris alcohol oxidase II regulatory region |
US4818700A (en) * | 1985-10-25 | 1989-04-04 | Phillips Petroleum Company | Pichia pastoris argininosuccinate lyase gene and uses thereof |
US4882279A (en) * | 1985-10-25 | 1989-11-21 | Phillips Petroleum Company | Site selective genomic modification of yeast of the genus pichia |
AU1469988A (en) * | 1985-10-25 | 1988-07-21 | Research Corporation Technologies, Inc. | Dna fragment |
US4895800A (en) * | 1985-11-26 | 1990-01-23 | Phillips Petroleum Company | Yeast production of hepatitis B surface antigen |
US4816564A (en) * | 1986-01-31 | 1989-03-28 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
US4812405A (en) * | 1986-02-18 | 1989-03-14 | Phillips Petroleum Company | Double auxotrophic mutants of Pichia pastoris and methods for preparation |
US5082778A (en) * | 1986-06-03 | 1992-01-21 | Unilever Patent Holdings B.V. | Production of guar alpha-galactosidase by hosts transformed with recombinant dna. methods |
US4857467A (en) * | 1986-07-23 | 1989-08-15 | Phillips Petroleum Company | Carbon and energy source markers for transformation of strains of the genes Pichia |
US5002876A (en) * | 1986-09-22 | 1991-03-26 | Phillips Petroleum Company | Yeast production of human tumor necrosis factor |
EP0263311A2 (fr) * | 1986-09-22 | 1988-04-13 | Phillips Petroleum Company | Production du facteur de nécrose de tumeurs par des levures |
US5026828A (en) * | 1987-02-27 | 1991-06-25 | Merck & Co., Inc. | Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast |
US4963483A (en) * | 1987-10-13 | 1990-10-16 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
US4929555A (en) * | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
US5011915A (en) * | 1987-10-26 | 1991-04-30 | Merck & Co., Inc. | Process for purifying recombinant hepatitis antigens |
GB2217332A (en) * | 1988-04-11 | 1989-10-25 | Phillips Petroleum Co | Expression of salmon growth hormone in methylotrophic yeast of genus pichia |
EP0337492A1 (fr) * | 1988-04-15 | 1989-10-18 | Research Corporation Technologies, Inc. | Purification de protéines de l'hépatite |
US5004688A (en) * | 1988-04-15 | 1991-04-02 | Phillips Petroleum Company | Purification of hepatitis proteins |
EP0339567A1 (fr) * | 1988-04-25 | 1989-11-02 | Phillips Petroleum Company | Expression de protéine de PreS 2 de l'hépatite B en levures méthylotrophiques |
EP0344459A2 (fr) * | 1988-04-25 | 1989-12-06 | Research Corporation Technologies, Inc. | Expression de l'albumine du sérum humain dans des levures méthylotrophigues |
WO1990002810A1 (fr) * | 1988-09-09 | 1990-03-22 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production de polypeptides d'interleukine-2 dans des cellules de levure de pichia pastoris |
WO1990003431A1 (fr) * | 1988-09-26 | 1990-04-05 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Fermentation de levure de recombinaison a alimentation melangee |
WO1990009434A1 (fr) * | 1989-02-13 | 1990-08-23 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production de peroxyde dismutase dans des cellules de levure de pichia pastoris |
WO1990010697A1 (fr) * | 1989-03-15 | 1990-09-20 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production du facteur de croissance epidermique dans des cellules methylotrophiques de levure |
US5102789A (en) * | 1989-03-15 | 1992-04-07 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production of epideramal growth factor in pichia pastoris yeast cells |
US5041236A (en) * | 1989-10-27 | 1991-08-20 | The Procter & Gamble Company | Antimicrobial methods and compositions employing certain lysozymes and endoglycosidases |
US5102989A (en) * | 1991-03-15 | 1992-04-07 | Merck & Co., Inc. | Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells |
Non-Patent Citations (7)
Title |
---|
BIO/TECHNOLOGY, Vol. 5, issued December 1987, TSCHOPP et al., "High-Level Secretion of Glycosylated Invertase in the Methylotrophic Yeast, Pichia Pastoris", pages 1305-1308. * |
DEV. IND. MICROBIOL., Vol. 29, issued 1988, CREGG et al., "Development of the Methylotrophic Yeast, Pichia Pastoris, as a Host System for the Production of Foreign Proteins", Abstract No. 89-00614. * |
GIM 90, Part I, issued 1990, THILL et al., "Positive and Negative Effects of Multiple Copy Intergrated Expression Vectors on Protein Expression in Pichia Pastoris", pages 477-490. * |
ICSU SHORT REPORT, Vol. 8, issued 1988, CREGG et al., "High-Level Expression and Secretion of Heterologous Proteins From the Methylotrophic Yeast Pichia Pastoris", Abstract No. 89-11304. * |
YEAST, Vol. 6, Special issue, s427, issued 1990, ROMANOS et al., "Expression of the Tetanus Toxin Fragment C in Saccharomyces", Abstract No. 90-13480. * |
YEAST, Vol. 6, Special issue, s435, Issued 1990, HODGKINS et al., "Secretion of HSA From Hansenula Polymorpha". * |
YEAST, Vol. 6, Special issue, s447, Issued 1990, STREEKRISHNA et al., "Expression of HSA in Pichia Pastoris". * |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5612198A (en) * | 1990-09-04 | 1997-03-18 | The Salk Institute | Production of insulin-like growth factor-1 in methylotrophic yeast cells |
US5831053A (en) * | 1991-04-01 | 1998-11-03 | Sibia Neurosciences, Inc. | Genes which influence pichia proteolytic activity, and uses therefor |
US5541112A (en) * | 1991-04-01 | 1996-07-30 | Salk Institute Biotechnology/Industrial Associates | Genes which influence pichia proteolytic activity, and uses therefor |
US5691166A (en) * | 1991-04-01 | 1997-11-25 | Sibia Neurosciences, Inc. | Genes which influence pichia proteolytic activity, and uses therefor |
US6051419A (en) * | 1991-04-01 | 2000-04-18 | Sibia Neurosciences, Inc. | Genes which influence pichia proteolytic activity, and uses therefor |
WO1995007356A1 (fr) * | 1993-09-04 | 1995-03-16 | Basf Aktiengesellschaft | Procede de preparation de proteines par recombinaison dans la levure d'hansenula |
US5741674A (en) * | 1993-09-04 | 1998-04-21 | Rhein Biotech Gesellschaft Fur Neue Biotechnologische Prozesse Und Produkte, Mbh | Recombinant production of proteins in yeast |
WO1995035384A1 (fr) * | 1994-06-17 | 1995-12-28 | Novo Nordisk A/S | Proteines comportant une extension a l'extremite n-terminale, exprimees par une levure |
US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
US6068995A (en) * | 1994-10-25 | 2000-05-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Method for producing protein |
EP0736605A4 (fr) * | 1994-10-25 | 1998-04-01 | Green Cross Corp | Procede de production de proteines |
EP0736605A1 (fr) * | 1994-10-25 | 1996-10-09 | The Green Cross Corporation | Procede de production de proteines |
EP0794256A2 (fr) * | 1996-03-04 | 1997-09-10 | Suntory Limited | Procédé de culture de micro-organismes capable de métaboliser le méthanol |
EP0794256A3 (fr) * | 1996-03-04 | 1998-06-17 | Suntory Limited | Procédé de culture de micro-organismes capable de métaboliser le méthanol |
US6171828B1 (en) * | 1996-03-04 | 2001-01-09 | Suntory Limited | Method for culturing microorganisms having a methanol metabolic pathway |
EP0947581A4 (fr) * | 1996-08-08 | 2004-07-28 | Mitsubishi Pharma Corp | Milieu de culture et ses applications |
EP0947581A1 (fr) * | 1996-08-08 | 1999-10-06 | Yoshitomi Pharmaceutical Industries, Ltd. | Milieu de culture et ses applications |
WO1999000518A1 (fr) * | 1997-06-26 | 1999-01-07 | Abbott Laboratories | Membre de la famille du facteur de necrose tumorale (tnf) utile pour le traitement et le diagnostic de maladies |
US6171787B1 (en) | 1997-06-26 | 2001-01-09 | Abbott Laboratories | Member of the TNF family useful for treatment and diagnosis of disease |
US6867037B1 (en) * | 1998-08-10 | 2005-03-15 | Meiji Dairies Corp. | High level secretory expression system of intact MK family protein |
EP1008651A2 (fr) * | 1998-12-09 | 2000-06-14 | Bioteknologisk Institut | Séquences d'ADN modifiées, codantes pour l'hexose oxidase, et leur usage |
EP1008651A3 (fr) * | 1998-12-09 | 2000-06-21 | Bioteknologisk Institut | Séquences d'ADN modifiées, codantes pour l'hexose oxidase, et leur usage |
US11084860B2 (en) | 2013-03-12 | 2021-08-10 | The General Hospital Corporation | Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases |
WO2015041718A1 (fr) * | 2013-09-20 | 2015-03-26 | The General Hospital Corporation | Utilisations de protéines de type hormone anti-müllérienne (ham) modifiée pour le traitement de maladies neurodégénératives |
US10258668B2 (en) | 2013-09-20 | 2019-04-16 | The General Hospital Corporation | Viral vectors for expressing a modified mullerian inhibiting substance (MIS) protein |
US11135269B2 (en) | 2013-12-11 | 2021-10-05 | The General Hospital Corporation | Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation |
US11518793B2 (en) | 2016-12-14 | 2022-12-06 | The General Hospital Corporation | Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation |
US11130979B2 (en) | 2017-06-20 | 2021-09-28 | Albumedix Ltd | Protein expression strains |
US11396670B2 (en) | 2017-06-20 | 2022-07-26 | Albumedix Limited | Protein expression strains |
EP4202035A1 (fr) | 2021-12-22 | 2023-06-28 | Gelita AG | Expression améliorée de peptides |
WO2023118318A1 (fr) | 2021-12-22 | 2023-06-29 | Gelita Ag | Expression améliorée de peptides |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2090969C (fr) | Production de facteur de croissance insulinoide dans les cellules de levure methylotrophiques | |
US5102789A (en) | Production of epideramal growth factor in pichia pastoris yeast cells | |
CA1318617C (fr) | Secretion accrue de proteines heterologues par des hotes utilisant des promoteurs de substitution | |
EP0195691B1 (fr) | Procédé pour la préparation de précurseurs d'insuline et procédé de préparation d'insuline humaine | |
FI104564B (fi) | Peptidi ja DNA-sekvenssit | |
FI90352C (fi) | Menetelmä heterologisten proteiinien tuottamiseksi Yarrowia lipolytica -transformanttien avulla, menetelmä Yarrowia lipolytica -transformanttien valmistamiseksi ja toteamiseksi sekä menetelmä transformanttien valmistamiseen käyttökelpoisten plasmidien valmistamiseksi | |
WO1992013951A1 (fr) | Production de serumalbumine humaine dans des cellules de levure methylotrophique | |
AU2733595A (en) | N-terminally extended proteins expressed in yeast | |
NZ212243A (en) | Yeast strains expressing modified recombinant insulin | |
WO1995002059A1 (fr) | Structure d'adn codant le peptide signal de yap3 | |
HU211600A9 (en) | Yeast expressing system | |
HU218731B (hu) | Élesztőtörzs és eljárás az élesztőre heterológ fehérjék előállítására | |
EP0213593A1 (fr) | Promoteurs répressibles de levure | |
US5612198A (en) | Production of insulin-like growth factor-1 in methylotrophic yeast cells | |
AU667852B2 (en) | Novel DNA molecules and hosts | |
EP0728191A1 (fr) | Sequence de secretion permettant de produire dans une levure une proteine heterologue | |
US5258302A (en) | DNA for expression of aprotinin in methylotrophic yeast cells | |
US4940661A (en) | Metallothionein transcription control sequences and use thereof | |
CA2357072C (fr) | Expression d'un precurseur de l'insuline humaine dans p. pastoris | |
Müller II et al. | Production of IFNα-2a in Hansenula polymorpha | |
US5182195A (en) | Method for increasing gene expression using protease deficient yeasts | |
US5104795A (en) | Shortened phosphoglycerate kinase promoter | |
WO1992004441A1 (fr) | Production de lisozyme humain dans des cellules de levure methylotrophe et ses secretions efficaces | |
EP0245479B1 (fr) | Promoteur de kinase de phosphoglycerate raccourci | |
EP1913143A1 (fr) | Expression de protéine améliorée |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP |